NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2026
Back to search
Official data from USPTO
CLAREST
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
03/11/2026
Trademark type
Word
Nice classes
35, 44
Filing date
12/22/2021
Registration date
03/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2026
Last transaction
03/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/30/2023
First use in commerce
06/30/2023
Drawing code
4
Owner type
16
Owner location
Towson, MD, US
Examiner
SAUNDERS, ANDREA DAWN
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Procare MSO LLC
Procare MSO LLC
Representatives
Janet P. Peyton McGuireWoods LLP
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical servicesprocessing online and telephone prescription orders in central fill pharmacies; mail order pharmacy services
Class 44
Preparation of prescriptions by pharmacists; pharmaceutical advice
Publications
History of USPTO decisions and trademark events.
44 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/15/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/15/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/17/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/17/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2025
IUAF
USE AMENDMENT FILED
07/11/2025
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2025
EX4G
SOU EXTENSION 4 GRANTED
06/09/2025
EXT4
SOU EXTENSION 4 FILED
06/09/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/09/2025
EX3G
SOU EXTENSION 3 GRANTED
06/06/2025
NREV
NOTICE OF REVIVAL - E-MAILED
06/03/2025
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
06/03/2025
PETG
PETITION TO REVIVE-GRANTED
06/03/2025
PROA
TEAS PETITION TO REVIVE RECEIVED
06/03/2025
EXT3
SOU EXTENSION 3 FILED
01/11/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/11/2024
EX2G
SOU EXTENSION 2 GRANTED
07/11/2024
EXT2
SOU EXTENSION 2 FILED
07/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/11/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/12/2024
EX1G
SOU EXTENSION 1 GRANTED
01/10/2024
EXT1
SOU EXTENSION 1 FILED
01/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/10/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/16/2023
PUBO
PUBLISHED FOR OPPOSITION
05/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/26/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/19/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/19/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/29/2022
GNRT
NON-FINAL ACTION E-MAILED
09/29/2022
CNRT
NON-FINAL ACTION WRITTEN
09/29/2022
DOCK
ASSIGNED TO EXAMINER
09/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/29/2021
NWAP
NEW APPLICATION ENTERED
12/25/2021
Continuous trademark protection
Get notified about every new filing that threatens CLAREST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.